Coincidence or not, the CEO of AM-Pharma, Bruno Giannetti, will be the new COO of Pharming as from December 1st. I am pretty sure that Pharming will want to draw on his sepsis experience, since sepsis is also one of the potential indications for Rhucin (rhC1inh), Pharming's lead product.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.